Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDIV × Neoplasms × Thoracic × Clear all

Phase

Status

Sponsor Class

INDUSTRY 355 OTHER 258 NIH 28 NETWORK 4 FED 3 UNKNOWN 1 OTHER_GOV 1 INDIV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 2 Thoracic 1 Other hematologic neoplasm 1 Other 1 Lymphoid 1 Head & Neck 1 CNS 1 Breast 1

Conditions

Lung Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Urinary Bladder Neoplasms 1 Prostatic Neoplasms 1 Pancreatic Neoplasms 1 Neutropenia 1 Neoplasms 1 Colorectal Neoplasms 1 Adenocarcinoma 1

Interventions

pegfilgrastim 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00050674 2012-12-27

Docetaxel and Gemcitabine With Filgrastim-SD/01 Support in Patients With Advanced Non-Small Cell Lung Carcinoma

Schwartzberg, Lee, M.D.

Phase 2 Completed

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasms, Neutropenia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡